ABRAHAM UBHENIN

Dr. ABRAHAM UBHENIN


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2023 in Heliyon
Verified
Journal Article
Open access
AUABRAHAM UBHENIN
ABRAHAM UBHENIN
AAAdedotun A. Adefolalu
Adedotun A. Adefolalu
KOKelly Oriakhi
Kelly Oriakhi
FAFatima Adis Adamude
Fatima Adis Adamude
EDEmeka Dingwoke
Emeka Dingwoke
KOKingsley Omage
Kingsley Omage
This study is aimed at evaluating the anticancer effect of the aqueous extract of Caesalpinia pulcherrima (L.) Sw in 7,12-Dimethlbenz[a]anthracene (DMBA) – induced mammary cancer. Tumors were induced via a single intraperitoneal injection of DMBA (dissolved in olive oil) at a dose of 80 mg/kg body weight to the test rats and allowed to develop for about four months. They were treated with cyclophosphamide and an aqueous extract of Caesalpinia pulcherrima at doses of 10 and 250 mg/kg body weight, respectively, for 28 days. Serum levels of cancer antigen 125 (CA125), carcinoembryonic antigen (CEA) activity, cyclooxygenase-2 (COX-2), and cytochrome p450 oxidase (cytp450) activity, as well as other diagnostic enzymes, were estimated. The result revealed that DMBA is associated with a significant (p < 0.05) increase in the serum levels of CA125, CEA, COX-2, cytp450, lactate dehydrogenase (LDH), alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) of the rats, thus suggesting tumor-promoting and hepatotoxic effects of DMBA. There was also a significant (p < 0.05) reduction of serum levels of these cancer and liver biomarker enzymes in the groups treated with cyclophosphamide and Caesalpinia pulcherrima compared to the untreated group, thus suggesting anticancer activity of Caesalpinia pulcherrima. The anticancer effect of Caesalpinia pulcherrima was further confirmed by the disappearance of infiltrative fibrous cells and the absence of inflammatory cells from the photomicrographs of the rats treated with Caesalpinia pulcherrima. Our findings show that Caesalpinia pulcherrima possesses anticancer activity, and could protect against mammary cancer.

10 March 2019 in Journal of Medicinal Plants Research
Verified
Journal Article
Open access
PDF file
AUABRAHAM UBHENIN
ABRAHAM UBHENIN
FAF. A. Adamude
F. A. Adamude
CNC. C. Nweze
C. C. Nweze
EDE. J. Dingwoke
E. J. Dingwoke
Since oxidative stress is implicated in the pathogenesis of liver diseases, this study was carried out to evaluate the hepatoprotective, hematoprotective and hypolipidemic effects of Pleurotus ostreatus (Oyster mushroom) in Carbon Tetrachloride (CCl4) induced liver injury in wistar rats. Thirty rats were used for this study. The rats were divided into five groups of six rats per cage. Group I that served as the normal control received distilled water only. Groups II to V served as test groups. Group II received CCl4 at a dose of 1 ml/kg body weight on the 14th day and 28th day only. Groups III, IV and V received CCl4 at a dose of 1 ml /kg body weight on the 14th day and 28th day, then, silymarin (100 mg/kg), 25% w/w and 50% w/w of powdered Oyster mushroom respectively. The results revealed that CCl4 caused a significant (p<0.05) increase in lipid peroxidation judging from the significant (p<0.05) elevated level of malondialdehyde MDA in the hepatic tissues whereas the level or activities of reduced glutathione (GSH), catalase (CAT), suproxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione S-transferase (GST) in the liver tissues were significantly (p<0.05) reduced. Liver peroxidation was followed by disruption of proper functioning of the hepatocytes as indicated by the significant increase of liver biomarker enzymes (AST, ALT, and ALP) and decreased serum levels of albumin and total protein. Dyslipidemia and hematotoxicity were also manifested via a significant (p<0.05) increase in the serum levels of triglyceride TG, total cholesterol TC, very low-density lipoprotein cholesterol VLDL-C, low density lipoprotein cholesterol LDL-C and white blood cells count. These were accompanied by significant (p<0.05) reduction in the serum level of high density lipoprotein cholesterol HDL-C and RBC count and its differentials. Supplementation of powdered Oyster mushroom daily for a period of 28 days to rats led to reversal of these signs of toxicities. The ability of the powdered Oyster mushroom to mitigate against CCl4-induced hepatotoxicity is probably due to its antioxidant and enzyme modulatory effects. Key words: Hepatoprotective, hematoprotective, hypolipidemic, Pleurotus ostreatus, carbon tetrachloride, peroxidation.

16 June 2025 in Sokoto Journal of Medical Laboratory Science
Verified
Journal Article
Open access
PDF file
AUABRAHAM UBHENIN
ABRAHAM UBHENIN
JIJoshua Onyeka Ikebuiro
Joshua Onyeka Ikebuiro
YAYusuf Nafisat Abdulmalik
Yusuf Nafisat Abdulmalik
TDTyem Lawal Danjuma
Tyem Lawal Danjuma
HIV remains a significant global public health challenge, with vulnerable populations in regions such as Sub-Saharan Africa, Asia, Eastern Europe, and Latin America bearing a disproportionate burden. This paper explores the latest research on HIV-1's immune evasion strategies, its impact on disease progression, and emerging therapies aimed at finding a cure. Despite advancements in treatment, including antiretroviral therapy (ART) and fixed-dose combination therapies that have made HIV a manageable chronic condition, the virus persists, especially in macrophages, which serve as key reservoirs of infection. HIV-1’s pathogenesis is further complicated by its ability to evade the immune system through immune activation, viral evolution, and coreceptor usage, with distinct strains (R5 and X4) influencing disease progression. Macrophages play a critical role in viral replication, contributing to HIV persistence, particularly in the brain and lymph nodes, which can lead to complications such as AIDS-related dementia. Recent research has provided valuable insights into the role of chemokine receptors like CCR5 and CXCR4 in HIV infection, as well as the CCR5 delta32 mutation, which has helped to enhance our understanding of HIV resistance and progression. The virus’s rapid mutation and immune evasion mechanisms continue to pose significant challenges in developing vaccines or achieving a cure. Additionally, the COVID-19 pandemic has disrupted HIV care, delaying testing, and treatment initiation, and complicating ART adherence, particularly for vulnerable populations . However, the integration of HIV and COVID-19 responses, along with innovations in telehealth and digital interventions, offers opportunities for new healthcare models.

11 January 2024 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
AUABRAHAM UBHENIN
ABRAHAM UBHENIN
JIJoshua Onyeka Ikebuiro
Joshua Onyeka Ikebuiro
FAFatima Anura
Fatima Anura
RIRamatu Iya Idris
Ramatu Iya Idris
OEOsayemwenre Erharuyi
Osayemwenre Erharuyi
Diabetic nephropathy is a progressive condition characterized by kidney damage and functional decline, primarily attributed to hyperglycemia. Special keywords and probes related to diabetic nephropathy were utilized by Google search engine to obtain relevant information from Google, Google Scholar, PubMed, Science Alert, and Google Scholar databases. This review explores the interconnected mechanisms underlying its pathogenesis. Hyperglycemia initiates glomerular hypertrophy and increased glomerular filtration rate as compensatory responses, but persistent hyperglycemia leads to renal inflammation, oxidative stress, abnormal extracellular matrix (ECM) accumulation, and increased albuminuria. These processes contribute to structural changes, declining glomerular filtration rate, and potential end-stage renal disease (ESRD) progression. Advanced glycation end products (AGEs) and the renin-angiotensin system (RAS) play key roles in hyperglycemic-induced glomerular hypertrophy. Glomerular hyperfiltration, mediated by the renin-angiotensin-aldosterone system (RAAS), impaired tubuloglomerular feedback, and increased capillary filtration coefficient, further contributes to increased glomerular filtration rate. Inflammation and oxidative stress, triggered by hyperglycemia and AGEs, promote kidney damage. Abnormal ECM accumulation, driven by hyperglycemia and the transforming growth factor-beta pathway, leads to structural changes. Hyperglycemia-induced microalbuminuria and proteinuria reflect early signs of kidney damage. Managing diabetic nephropathy poses challenges, but ongoing research offers potential solutions. Novel therapeutic targets, combination therapies, personalized medicine approaches, regenerative medicine, and gene therapy are being explored. Advancements in diagnostics, including targeted therapies and non-invasive tools, show promise in preventing or mitigating the progression of diabetic nephropathy. Understanding these mechanisms is crucial for early detection, glycemic control, blood pressure management, and targeted therapies to slow disease progression. Collaboration among healthcare stakeholders is essential in finding effective solutions for this complex condition. This review therefore highlights the importance of a comprehensive approach to managing diabetic nephropathy and improving patient outcomes.

16 June 2025 in Sokoto Journal of Medical Laboratory Science
Verified
Journal Article
Open access
PDF file
AUABRAHAM UBHENIN
ABRAHAM UBHENIN
FAFatimah Anura
Fatimah Anura
RIRamatu Iya Idris
Ramatu Iya Idris
HSHassan Sani
Hassan Sani
Alcohol’s historic role in human culture contrasts with its modern health burden. This review synthesizes extensive research on the adverse effect of alcohol on organ systems, contributing to chronic diseases. Global data shows that alcohol consumption has a substantial impact on disease burden and mortality. In Nigeria, high alcohol use rates among males correlate with liver diseases, hypertension, stroke, cognitive impairment, and accidents, demanding targeted interventions. Examining specific organ systems reveals alcohol damage. The liver experiences fatty liver, hepatitis, fibrosis, and cirrhosis due to lipid disruption, oxidative stress, and inflammation. Gastrointestinal issues arise from gastritis, ulcers, and compromised barriers. Neurological consequences include diseases, cognitive impairments, neuropathy, and increased stroke risk. Alcohol affects cardiovascular health, causing cardiomyopathy, hypertension, arrhythmias, and altered lipid profiles. Immune suppression raises infection risk, impairs vaccine response, and influences cancer immunity. Reproductive health, cancer risk, metabolic disturbances, bone health, and muscle atrophy are compromised by alcohol. Emerging research explores plant-derived compounds like silymarin and curcumin for potential mitigation. Alcohol-induced toxicities involve complex mechanisms requiring further research to obtain comprehensive insights and evidence-based strategies to address excessive alcohol consumption and its consequences.

29 January 2024 in Journal of Applied Sciences and Environmental Management
Verified
Journal Article
Open access
PDF file
AUABRAHAM UBHENIN
ABRAHAM UBHENIN
SIS. O. Innih
S. O. Innih
FAF. Anura
F. Anura
RIR. I. Idris
R. I. Idris
The aim of this study is to offer a thorough examination of contemporary research concerning cardiovascular complications induced by diabetes, with a specific focus on coronary artery disease (CAD), diabetic heart attacks, diabetic peripheral artery disease (PAD), and diabetic hypertension. The period of analysis spans from 1988 to 2022, and the data utilized is extracted from secondary sources. Diabetes mellitus is a chronic metabolic disorder associated with an increased risk of cardiovascular complications, including coronary artery disease (CAD), heart attacks, strokes, peripheral artery disease (PAD), and hypertension. These complications are influenced by chronic hyperglycemia, insulin resistance, dyslipidemia, inflammation, and endothelial dysfunction. Diabetic-induced cardiovascular diseases significantly contribute to morbidity and mortality rates worldwide. The studies highlight the potential of plant-derived targeted therapies in reducing inflammation and endothelial dysfunction, providing promising avenues for improving patient outcomes. Additionally, research on diabetes-specific medications, imaging techniques, individualized glycemic targets, and combination therapies reveals new approaches to managing diabetic-induced cardiovascular diseases. Precision medicine, advancements in imaging, and lifestyle interventions offer valuable tools for personalized treatment plans and improved patient care. Public health initiatives that enhance diabetes management, raise awareness, and improve healthcare access are crucial for reducing the burden of cardiovascular complications in Nigeria and other regions affected by diabetes. Further research and collaboration among healthcare professionals will refine our understanding and enhance the management of diabetic-induced cardiovascular diseases, ultimately reducing their impact on individuals with diabetes.